Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 million up front to begin the collaboration. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on…
Zuckerberg San Francisco General Hospital’s Lucas Zier, M.D., saw an opportunity to use the EHR for system-wide performance improvement
Most of the 24 million people in Affordable Care Act health plans face a potential one-two punch next year — double-digit premium increases along with a sharp drop in the federal subsidies that most consumers depend on to buy the coverage, also known as Obamacare. Insurers want higher premiums to cover the usual culprits —…
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher. The post Earlier Detection and Treatment are Essential for Meeting VBC Goals appeared first on MedCity News.
As economists offer up their best guesses for the US economy over the coming year, healthcare leaders know one thing for sure: no matter what happens, they need solid revenue cycle management (RCM) processes to remain financially sound and deliver high-quality care. Revenue cycle management connects the financial and clinical aspects of care by ensuring…
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Ayuda Medical offers a wearable device that can detect an overdose and call for help. The company has received support from the NIH and NIDA via the Small Business Innovation Research program. The post How One Company is Using an Armband to Combat the Overdose Crisis appeared first on MedCity News.
KFF’s Tracking Poll on Health Information and Trust finds that just over half of adults use social media for health information and advice at least occasionally but fewer than half say they find “most” or “some” of the information they see on each platform trustworthy.
That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…
Promoting price transparency in health care is a policy approach with bi-partisan support in Congress and the public at large. This analysis examines the vast troves of price transparency data that payers are required and finds unlikely prices, inconsistencies, and other oddities that pose major challenges for efforts to use it to promote competition and…